Crispr Therapeutics shares owned by National Bank Of Canada /fi/
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by National Bank Of Canada /fi/
from 13F filings
Historical chart of National Bank Of Canada /fi/ investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by National Bank Of Canada /fi/ consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by National Bank Of Canada /fi/
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $636k | 9.8k | 64.73 |
| 2025-06-30 | $36M | 736k | 48.64 |
| 2024-06-30 | $46k | 848 | 53.76 |
| 2024-03-31 | $32k | 628 | 51.10 |
| 2023-12-31 | $44k | 668 | 65.99 |
| 2023-09-30 | $78k | 1.8k | 42.30 |
| 2023-06-30 | $78k | 1.4k | 56.12 |
| 2023-03-31 | $67k | 1.5k | 45.23 |
| 2022-12-31 | $60k | 1.5k | 40.65 |
| 2022-09-30 | $113k | 1.7k | 65.08 |
| 2022-06-30 | $72k | 1.2k | 60.47 |
| 2022-03-31 | $103k | 1.6k | 62.97 |
| 2021-12-31 | $88k | 1.2k | 75.99 |
More positions owned by National Bank Of Canada /fi/
View all positions for National Bank Of Canada /fi/